- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03543475
Cervical Pessary for Prevention of Spontaneous Preterm Birth in Singleton Pregnancies With Arrested Preterm Labor
Cervical Pessary for Prevention of Spontaneous Preterm Birth in Singleton Pregnancies With Arrested Preterm Labor: a Randomized Controlled Trial
Preterm birth (PTB) is a major cause of perinatal morbidity and mortality. Worldwide, about 15 million babies are born too soon every year, causing 1.1 million deaths, as well as short- and long-term disability in countless survivors.
Different strategies have been studied for prevention of spontaneous PTB (SPTB) in randomized controlled trials (RCTs), including progesterone, cerclage, cervical pessary, as well as lifestyle modification, such as smoking cessation, diet, aerobic exercise, and nutritional supplements. Most successful effort to reduce the incidence of SPTB have focused on asympatomatic women with risk factors, such as prior SPTB or short cervix. However, most SPTB occur in symptomatic women, i.e. women with preterm labor (PTL). Women with arrested PTL are at increased risk of SPTB.
The cervical pessary is a silicone device that has been used to prevent SPTB. The leading hypotheses for its mechanisms are two: that the pessary helps to keep the cervix closed, and that the pessary changes the inclination of the cervical canal so that the pregnancy weight is not directly above the internal os.
The aim of the study is to assess the efficacy of pessary in reducing preterm birth in women with arrested preterm labor
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Naples, Italy, 80100
- University of Naples Federico II
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Singleton gestations
- Diagnosis of arrested PTL
- 18-50 years of age
- TVU CL ≤25mm at the time of randomization
Exclusion Criteria:
- Multiple gestations
- Rupture of membranes at the time of randomization
- Known major fetal structural (i.e. defined as those that are lethal or require prenatal or postnatal surgery) or chromosomal abnormality
- Fetal death at the time of randomization
- Cerclage in situ at the time of randomization
- Pessary in situ at the time of randomization
- Vaginal bleeding at the time of randomization
- Women who are unconscious, severly ill, mentally handicapped, or under the age of 18 years
- Placenta previa and/or accreta
- Ballooning of membranes outside the cervix into the vaginal or TVU CL = 0mm at the time of randomization
- Painful and regular uterine contractions at the time of randomization
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Pessary
Silicon device applied on the cervix
|
arabin pessary: silicon device
|
ACTIVE_COMPARATOR: No Pessary
standard care, no pessary
|
control group
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pre-term Birth
Time Frame: at the time of delivery
|
delivery before 37 weeks of gestations
|
at the time of delivery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pre-term Birth <34, <32, and <28 weeks
Time Frame: at the time of delivery
|
delivery before 34, 32, and 28 weeks
|
at the time of delivery
|
Mean gestational age at delivery in weeks
Time Frame: at the time of delivery
|
Mean gestational age at delivery in weeks
|
at the time of delivery
|
Mean latency in days
Time Frame: at the time of delivery
|
Time from randomization to delivery
|
at the time of delivery
|
Maternal side effects related to the intervention
Time Frame: at the time of delivery
|
any maternal adverse events
|
at the time of delivery
|
Chorioamnionitis
Time Frame: at the time of delivery
|
inflammation of the chorion and amnion by histopathological assessment after delivery
|
at the time of delivery
|
Composite adverse perinatal outcome
Time Frame: Between birth and 28 days of ag
|
Includes Nectrotizing Enterocolitis, Intraventricular Hemorrhage, Respiratory Distress syndrome, Bronchopolmunary dysplasia,Retinopathy of Prematurity, Blood-culture proven sepsis, Neonatal death.
|
Between birth and 28 days of ag
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 103/18
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Preterm Birth
-
e-Bio CorpRecruitingPreterm Labor | PreTerm Birth | Preterm Labor With Delivery NosUnited States
-
Thomas Jefferson UniversityCompleted
-
Chelsea and Westminster NHS Foundation TrustSPD Development Company Limited; Borne CharityRecruitingPreterm Birth | Preterm Labor | Preterm Birth Complication | Preterm Premature Rupture of Membrane | Preterm PregnancyUnited Kingdom
-
Cairo UniversityCompleted
-
University of OklahomaCompletedPreTerm Birth | PreTerm NeonateUnited States
-
Federico II UniversityRecruiting
-
University of OxfordShoklo Malaria Research UnitCompleted
-
PreTeL, IncDuke University; University of RochesterRecruitingPreterm Birth | Threatened Preterm Labor | PreTerm LaborUnited States
-
Eunice Kennedy Shriver National Institute of Child...CompletedPregnancy | Preterm Birth | Preterm LaborUnited States
-
University Hospital Inselspital, BerneAmniSure International LLCCompletedPreterm Birth | Preterm LabourSwitzerland
Clinical Trials on arabin pessary
-
The George Washington University Biostatistics...Eunice Kennedy Shriver National Institute of Child Health and Human Development...TerminatedPreterm Delivery | Short CervixUnited States
-
Zeynep Kamil Maternity and Pediatric Research and...Unknown
-
Federico II UniversityWithdrawn
-
Bürgerhospital FrankfurtNot yet recruitingPremature Birth | Preterm BirthGermany, Spain, Australia, Greece
-
National University of MalaysiaCompletedPrevious Mid Trimester Miscarriage | Previous Preterm Birth | Previous Cervical Surgery | Short Cervix on UltrasoundMalaysia
-
Bürgerhospital FrankfurtNot yet recruitingPremature Birth | Preterm BirthGermany, Spain, Australia, Greece
-
University of EdinburghNHS LothianCompletedTwin Pregnancy With Antenatal ProblemBelgium, United Kingdom
-
Gene Lee, MDMedical University of South CarolinaTerminatedPremature BirthUnited States
-
University of Illinois at ChicagoTerminatedFocus: Prevent Preterm Delivery | Incidental Short Cervix at Mid-trimesterUnited States
-
Mario Henrique Burlacchini de CarvalhoUnknownPreterm Birth | Twin Pregnancy With Antenatal ProblemBrazil